Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Appoints Two Scientists to New Research Positions

Premium

CAMBRIDGE, Mass.--Millen nium Pharmaceuticals here has announced two major scientific appointments. Michael Pavia will become the company's chief technology development officer, while Kazumi Shiosaki will be senior director of drug discovery.

Pavia was formerly vice-president of Cambridge Research with the Sphinx Pharmaceuticals division of Eli Lilly. He has a background of over 15 years in pharmaceutical research and discovery, including stints with Genesis Pharmaceuticals and Parke-Davis. In his new position he will head the organization dedicated to Millennium's technology development efforts in such areas as informatics, proteomics, process technologies, systems, transcriptional profiling, technology transfer, and technology acquisition. The company said his responsibilities will include "advancing the development and implementation of Millennium's integrated platform of genomic technologies for broad application in the life sciences arena."

Meanwhile, Shiosaki will lead Millennium's drug discovery group, taking responsibility for such areas as assay development, screening, drug source, and chemistry. With over 13 years of experience in pharmaceutical research and development, she most recently worked at Abbott Laboratories, serving as senior project leader and associate fellow of the Volwiler Society, Antiviral Research. In her new position Shiosaki will direct Millennium's efforts in drug discovery, high-throughput screening, and lead optimization.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.